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A major problem for structural characterization of membrane proteins, such as connexins,
by nuclear magnetic resonance (NMR) occurs at the initial step of the process, the
production of sufﬁcient amounts of protein. This occurs because proteins must be
expressed inminimal basedmedia. Here, we describe an expression system formembrane
proteins that signiﬁcantly improves yield by addressing two common problems, cell toxicity
caused by protein translation and codon bias between genomes. This work provides
researchers with a cost-effective tool for NMR and other biophysical studies, to use
when faced with little-to-no expression of eukaryotic membrane proteins in Escherichia
coli expression systems.
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INTRODUCTION
Membrane proteins play a fundamental role in human dis-
ease and constitute a major portion of drug targets; lacking
is sufﬁcient structural and functional information compared to
soluble proteins (Drew et al., 2003; Molina et al., 2008). The
limitations can be traced to difﬁculties in expression, opti-
mizing puriﬁcation procedures, and reconstituting the proper
fold in a lipid environment. Yield is a major problem because
only a few membrane proteins are expressed in large-enough
quantities to be collected from natural sources. Strategies devel-
oped to overcome this problem include engineering vectors to
express membrane proteins in S. cerevisiae yeast, Sf9 insect, and
Escherichia coli bacteria cell expression systems (Bernaudat et al.,
2011).
Escherichia coli is a widely used host for the production of
heterologous proteins due to its ability to grow rapidly at high
density and in inexpensive substrates (Molina et al., 2008). The
E. coli strain BL21 is extensively used for protein expression
because it is deﬁcient in lon and ompT proteases (Ratelade
et al., 2009). The BL21(DE3) version carries a chromosomal
copy of the T7 RNA polymerase gene under control of the
lacUV5 promoter, suitable for protein production from target
genes cloned into any T7 vector (e.g., pET) by induction with
isopropyl-β-D-thiogalactopyranoside (IPTG; Studier and Moffatt,
1986; Unger et al., 1999). However, problems still arise because
bacteria have difﬁculties folding membrane proteins and expres-
sion can be toxic (Miroux and Walker, 1996; Laible et al., 2004).
Derivatives of BL21(DE3) called the Walker strains, C41(DE3)
and C43(DE3), were therefore created with an enhanced abil-
ity to express otherwise toxic membrane proteins (Miroux and
Walker, 1996). C41(DE3) was derived from the BL21(DE3)
strain through natural selection to survive expression of the
oxoglutarate-malate carrier protein from mitochondrial mem-
branes. C41(DE3) has at least one uncharacterized mutation,
enablingmembraneprotein expression into inclusionbodieswith-
out toxic effects (Miroux and Walker, 1996). Because expression
of other membrane proteins were still toxic in the C41(DE3)
strain, C43(DE3) was derived from C41(DE3) by selecting
resistance to the F-ATPase b subunit gene. Thus, C43(DE3)
can express a different set of toxic membrane proteins than
C41(DE3).
Eukaryotic protein expression by E. coli is also strongly affected
by codon bias. The genetic code contains 64 possible nucleotide
combinations, which encode 20 amino acids and three codons
that terminate translation. The frequencies with which differ-
ent codons are used, which correlates with the amount of their
corresponding tRNAs, vary between organisms (Gouy and Gau-
tier, 1982). For example, eukaryotes commonly use the AGG
codon for Arginine, which is rarely used in E. coli (Novy et al.,
2001; Gustafsson et al., 2004). Expressing an eukaryotic gene with
numerous rare codons in bacteria can impact expression through
premature termination of translation, translational stalling, frame
shifting, and mis-incorporation of amino acids (Kurland and Gal-
lant, 1996). This problem can be solved by exchanging rare codons
in the target gene for more frequently used codons in E. coli or
by expressing the rare tRNAs. The latter has been implemented
through creation of the BL21(DE3)-derived Rosetta (Novagen)
and BL21(DE3)-CodonPlus (Agilent Technologies) strains. These
strains contain a plasmid to express eukaryotic tRNAs rarely used
in E. coli. For example, the pLysS plasmid within the Rosetta
2(DE3)pLysS strain carries tRNA genes that encode for seven
rare codons, including AGG (Novy et al., 2001). Many studies
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have shown that protein expression is enhanced in these strains
(Kane, 1995).
Every membrane protein is unique in the challenges needed
to obtain a sample viable for structural studies. The increased
number of possible methodologies at each step will help save
researcher’s time and money, and more importantly may pro-
vide ideas for future improvements. Previous Cx43 studies from
our laboratory identiﬁed that tethering of the CT domain to TM4
was necessary to elicit a change in secondary structure in response
to factors known to regulate gap junction channels (Kellezi et al.,
2008; Grosely et al., 2013). Therefore, our studies were extended to
test the expression of other connexin carboxyl-terminal domains
when attached to their 4th transmembrane domain (TM4-CxCT;
Cx26, Cx32, Cx37, Cx40, Cx45, and Cx50). This is the ﬁrst critical
step toward structural characterization of theirCTdomains. These
isoforms were chosen for investigated because of their known
functional signiﬁcance and involvement in human disease (for
review, see Laird, 2010; Zoidl and Dermietzel, 2010). The protocol
developed for TM4-Cx45CT expression will be described in detail,
as an example of the TM4-CxCT domains. Cx45 is highlighted
because of the unique expression requirements in comparison to
the other isoforms. Cx45 is the ﬁrst cardiac connexin expressed
during embryonic development and plays an important role in
propagating the action potential from the conduction system
to the working myocardium (Severs et al., 2006; Palacios-Prado
et al., 2010). Cx45 gap junction channels close when the mem-
brane potential becomes negative, which has been suggested to
prevent retrograde conduction from the myocardium to the con-
duction system (Palacios-Prado et al., 2010). Cx45 has limited
expression in normal, working ventricular myocytes; however,
in failing heart tissue, an up-regulation of Cx45 reduces the cell-to-
cell coupling while promoting arrhythmogenesis, especially when
superimposed on the down-regulation of Cx43 (Yamada et al.,
2003; Betsuyaku et al., 2005).
Development of the methods described herein has resulted in
protein yields that are at the levels necessary for biophysical charac-
terization (e.g., circular dichroïsm (CD), isothermal calorimetry,
etc.), including structural analysis by nuclear magnetic resonance
(NMR). This methodology will be of general usage for other
intrinsically ordered domains from membrane proteins.
MATERIALS AND METHODS
GENERATION OF THE TM4-CxCT CONSTRUCTS
TM4-CxCT domains used in this study were from the Cx50,
Cx45, Cx43, Cx40, Cx37, Cx32, and Cx26 isoforms. Table 1
provides the amino acid sequence and species used for each
TM4-CT domain to clone and ligate into the pET-14b expression
vector (N-terminal 6× His-tag, ampicillin resistance; Novagen).
Each construct includes 10 residues prior to their predicted TM4
domain (e.g., TM4-Cx45CT, Figure 1). All plasmid sequences
were veriﬁed at the University of Nebraska Medical Center DNA
Sequencing Core Facility.
PURIFICATION OF THE TM4-Cx45CT
Puriﬁcation of the TM4-Cx45CT was based on the protocol devel-
oped for the TM4-Cx43CTdomain (Kellezi et al., 2008). Cells were
resuspended in 1× PBS buffer containing a bacterial protease
inhibitor cocktail (250 μL/4 L cells; Sigma-Aldrich) and 1 mM
β-mercaptoethanol. Cells were then lysed with an Emulsiﬂex-C3
(Avestin) for three passages at 15,000 psi. Cell debris was removed
with centrifugation (4,000 rpm, 1 h) and a pellet containing the
inclusion bodies was collected by centrifugation (18,000 rpm, 1 h).
The pellet was resuspended in 50 mL Buffer A (6 M urea, 1×
PBS, 20 mM imidazole, and 1 mM β-mercaptoethanol, 1% Tri-
ton X-100, pH 8.0) and rocked overnight at 4◦C. The suspension
was centrifuged again (18,500 rpm, 1 h), and the supernatant
was loaded onto an ÄKTA FPLC using a HisTrap HP column
(GE Healthcare). Protein elution was accomplished using a step
gradient (4, 8, 10, 30, and 50%) of Buffer B (6 M urea, 1×
PBS, 1 M imidazole, 1 mM β-mercaptoethanol, and 1% Triton
X-100, pH 8.0). Fractions that contained the 22 kDa His-tagged
TM4-Cx45CT protein (veriﬁed by SDS-PAGE and Western blot
analyses) were pooled and dialyzed overnight at 4◦C using a
10,000 MW cut off Slide-A-Lyzer dialysis cassette (Pierce) against
buffer C [1 M urea, 1 mM dithiothreitol (DTT), 1 mM EDTA,
and 1% Triton X-100]. The precipitate was collected and cen-
trifuged (4,000 rpm, 5 min), washed twice with water then buffer
D (20mMMESbuffer, 1mMDTT,1mMEDTA,and 50mMNaCl,
pH 5.8). The washed precipitate was then solubilized in buffer E
(20 mM MES, 1 mM DTT, 8% 1-palmitoyl-2-hydroxy-sn-glycero-
3-[phospho-RAC-(1-glycerol)] (LPPG; Avanti Lipids), and 1 mM
Table 1 | Conditions used to produce NMR samples for eachTM4-CxCT construct.
Connexin isoform Species Optimal cell line LB media‡ M63 minimal media‡
TM4-Cx26CT (D179-V226) Homo sapiens C41 1.5 6
TM4-Cx32CT (D178-C283) Rattus norvegicus C41, C41Rt, R2 1.5 6
TM4-Cx37CT (D197-V333) Mus musculus C41, C41Rt 6 8
TM4-Cx40CT (N194-V356) Rattus norvegicus C41 10 12
TM4-Cx43CT (D197-I382) Rattus norvegicus C41 12 12
TM4-Cx45CT (D219-I396) Mus musculus C41Rt 10 8*
TM4-Cx50CT (D200-I440) Mus musculus C41, C41Rt, BL21 1 2
Abbreviations used for E. coli competent cell stains: C41, C41(DE3); R2, Rosetta2(DE3)pLysSRARE2; C41Rt, C41(DE3)pLys; BL21, BL21(DE3).
‡Liters of bacterial culture required to produce a 300 μL sample at 1 mM concentration.
*ISOGRO required for TM4-Cx45CT expression in minimal media.
Frontiers in Pharmacology | Pharmacology of Ion Channels and Channelopathies August 2013 | Volume 4 | Article 106 | 2
“fphar-04-00106” — 2013/8/21 — 17:44 — page 3 — #3
Kopanic et al. Expression of TM4-CxCT constructs
FIGURE 1 | Model of theTM4-Cx45CT construct. (A) Schematic diagram
of full length Cx45. The black coloring represents theTM4-Cx45CT
construct. (B)The amino acid sequence of theTM4-Cx45CT (D219-I396)
contains a portion of the EL2 (line) and the entire TM4 (bold) and CT (arrow)
domains.
EDTA) and incubated at 42◦C for 30 min. Buffer E was used for
all TM4-Cx45CT experiments.
WESTERN BLOT ANALYSIS
Protein samples were separated on 15% SDS-PAGE gels and trans-
ferred to a 0.45 μ polyvinylidene diﬂuoridemembrane (Millipore)
equilibrated in transfer buffer (192 mM glycine, 25 mM Tris,
0.05% SDS, 10% methanol) using an electrophoretic transfer cell
for 90 min at 100 V. After incubation with 5% non-fat milk
in 1× PBS for 2.5 h, membranes were incubated with either
mouse monoclonal anti-Cx45 (1:2,000, Cx45CR1 clone P3C9,
Fred Hutchinson Cancer Center) or anti-His (1:2,000, His-Tag
27E9, Cell Signaling Technology, gift from Dr. Surinder Batra)
for 16 h, 4◦C. Membranes were washed four times at room
temperature with washing buffer (0.1% Tween-20 in 1× PBS)
for 10 min. Membranes were then incubated with goat anti-
mouse IgG secondary antibody horseradish peroxidase conjugates
(1:12,000, 12-349, Millipore) for 1 h, 25◦C, then washed again.
Bound antibodies were visualized using SuperSignal West Femto
(Thermo Scientiﬁc).
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
All NMR data were acquired using a 600 MHz Varian INOVA
NMR Spectrometer outﬁtted with a cryo-probe at the Univer-
sity of Nebraska Medical Center’s NMR Facility. NMR spectra
were processed and phased using NMRPipe and NMRDraw
(Delaglio et al., 1995) and analyzed using NMRView (Johnson,
2004). Gradient-enhanced two-dimensional 15N-HSQC experi-
ments were acquired with 1,024 complex points in the direct
dimension and 256 complex points in the indirect dimension (Kay
et al., 1992). Sweep widths were 10,000 Hz in the 1H dimension
and 2,430.6 Hz in the 15N dimension.
CIRCULAR DICHROÏSM SPECTROSCOPY
Circular dichroïsm experiments were performed using a Jasco
J-815 spectrophotometer ﬁtted with a Peltier temperature control
system. For each sample, ﬁve scans (wavelength range: 300–
190 nm; response time: 1 s; scan rate: 50 nm/min; bandwidth
1.0 nm) were collected using a 0.01 cm quartz cell and processed
using Spectra Analysis (Jasco). Each spectrum is shown as the
mean residue ellipticity (MRE; deg cm2 dmol−1) as a function
of wavelength and average of ﬁve scans. All spectra were cor-
rected by subtracting the solvent spectrum. Protein concentrations
were determined using a NanoDrop 1000 (Thermo Scientiﬁc) or
Biospec 1601 UV-VIS spectrophotometer (Shimadzu) at 280 nm.
Analyses of spectra were accomplished using the Provencher and
Glöckner method with the SP175 reference set on the online pro-
gram DichroWeb (Provencher and Glöckner, 1981;Whitmore and
Wallace, 2004; Lees et al., 2006).
RESULTS
BACTERIAL STRAINS USED FOR PROTEIN EXPRESSION
The E. coli strains BL21(DE3), C41(DE3), C43(DE3), and Rosetta
2(DE3)pLysS (chloramphenicol resistance)were transformedwith
the TM4-Cx45CT plasmid and incubated in lysogeny broth (LB)
medium at 37◦C, 250 rpm. Rosetta 2(DE3)pLysS expresses seven
rare codons (Arg, AGA, AGG, CGA, CGG; Ile, AUA; Pro, CCC,
Leu, CUA) in comparison to the BL21-Codon Plus(DE3)-RIPL
strain (contains the most amount of tRNA genes in the BL21-
Codon Plus series), which contains only ﬁve tRNA genes (Arg,
AGA, AGG; Ile, AUA; Pro, CCC, Leu, CUA). The TM4-Cx45CT
contains ﬁveArg rare codons, including twoCGA,which theBL21-
Codon Plus(DE3)-RIPL strain does not have the corresponding
tRNA. Therefore, Rosetta 2(DE3)pLysS was chosen as the repre-
sentative strain that expresses rare codons for this study. Protein
expressionwas inducedby the additionof 1.0mMIPTG(ﬁnal con-
centration; Bioexpress) at an optical density of 0.6 at 600 nm. The
electrophoretic proﬁle of total cellular proteins obtained 4 h after
induction indicated that only C41(DE3) and C43(DE3) expressed
TM4-Cx45CT (Figure 2, lanes 5 and 7, respectively). However,
this protein yield is not optimal as signiﬁcantly less protein per
liter was produced then what was needed for the TM4-Cx43CT
NMR structural studies (Kellezi et al., 2008). Upon examination of
the TM4-Cx45CT gene sequence, 14 rare codons were identiﬁed;
of these, eight (two in tandem) translate to the amino acid with
the greatest codon bias, Arg (Table 2). Even though the Rosetta
2(DE3)pLysS strainwas unable to expressTM4-Cx45CT (Figure 2,
lane 13), we hypothesized that expression would be enhanced by
combining the pLysS plasmid with the C41(DE3) or C43(DE3)
strains.
EXPRESSION OF TM4-Cx45CT WITH THE pLysS PLASMID
The pLysS (also referred to as pLysSRARE2) plasmid was isolated
from Rosetta 2(DE3)pLysS cells using the QIAprep Spin Miniprep
Kit (Qiagen) and co-transformed with the TM4-Cx45CT plasmid
into the C41(DE3) and C43(DE3) strains. The cells were grown
and induced as described above. The electrophoretic proﬁle of
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FIGURE 2 |TM4-Cx45CT expression profile obtained from different
E. coli (DE3) strains with and without the pLysS plasmid in LB
medium.TM4-Cx45CT was expressed in the following E. coli cell strains:
BL21(DE3) (lanes 2 and 3), C41(DE3) (lanes 4 and 5), C43(DE3) (lanes 6 and
7), C41(DE3)pLysS (lanes 8 and 9), C43(DE3)pLysS (lanes 10 and 11), and
Rosetta 2(DE3)pLysS (lanes 12 and 13). Lanes 1 and 14 contain the
Precision Plus Protein All Blue Standards molecular mass marker (Bio-Rad).
Samples were collected just prior to (uninduced; U) and 4 h after IPTG
induction (I), as noted. All lanes contain an equal amount of total protein for
comparison. This was accomplished by pelleting 500 μL samples with an
Abs600 nm at 0.5 and resuspending the pellet in 30 μL of 6× SDS loading
buffer. Five microliters of the samples were ran on a 15% SDS-PAGE gel
and stained with Coomassie Blue. TheTM4-Cx45CT has an expected
molecular mass of ∼22 kDa, indicated by the arrow.
total cellular proteins obtained 4 h after induction showed that
TM4-Cx45CT expression in C43(DE3) was similar with and with-
out transformation of the pLysS plasmid (Figure 2, lanes 7 and
11, respectively). Conversely, TM4-Cx45CT expression was sig-
niﬁcantly increased in the C41(DE3)pLysS strain as compared to
C41(DE3) alone (Figure 2, lanes 9 and 5, respectively). The expres-
sionwas quantiﬁed by densitometry and revealed that the addition
of the pLysS plasmid increased TM4-Cx45CT expression by 70%
in C41(DE3). The expression of TM4-Cx45CT was conﬁrmed by
Western blot analyses using anti-His6 and anti-Cx45 antibodies
(Figure 3).
Expression using the C41(DE3)pLysS strain was tested in iso-
topically labeled M63 minimal medium, which allows the control
of nitrogen and carbon sources needed for NMR structural stud-
ies. The TM4-Cx45CT expression level decreased 84% in M63 as
compared to LB (Figure 4, lanes 6 and 3, respectively). However,
expression was restored to LB level when M63 was supplemented
with 15N-ISOGRO (1 g/L, Isotec; Figure 4, lane 9). ISOGRO is
an algal lysate-derived complex labeling medium that provides
cells a metabolic boost that often decreases lag time, facilitates
the attainment of growth saturation, and promotes recombi-
nant protein production. ISOGRO helps cultures conserve cellular
energy by limiting the requirement for de novo synthesis of cellu-
lar machinery and metabolic precursors; permitting more cellular
resources to be direct toward recombinant protein expression.
At this expression level, 8 L of growth is necessary to obtain
Table 2 | Rare codon usage for eachTM4-CxCT domain.
Connexin
isoform
Number of rare codons‡










































2 ATA 1 CTA 3 CCC 12 No
‡Number of rare codons was determined using the Rare Codon Calculator
(http://nihserver.mbi.ucla.edu/RACC/).
a 1 mM at 300 μL volume (“gold standard” concentration and
volume for NMR structural studies; Table 1). This is in con-
trast to the 54 or 180 L would be necessary in M63 without
15N-ISOGRO or without 15N-ISOGRO and the pLysS plasmid,
respectively.
Another advantage of using the pLysS plasmid is the suppres-
sion of T7 RNA polymerase expression prior to induction with
IPTG. The phenotypes observed from “leaky” expression (before
IPTG induction) of a membrane protein that is toxic to E. coli are
a slow growth rate, low cell density, and in some cases, cell death.
The TM4-Cx45CT expression was not toxic to the E. coli strains
tested as the growth rates and ﬁnal cell densities were identical
with and without the pLysS plasmid (Figure 5), indicating that
the beneﬁt gained from the pLysS plasmid was solely the tRNAs
expression.
EXPRESSION OF OTHER TM4-CxCT CONSTRUCTS
Outlined in Table 1 are the results from the other six connexin
isoforms. With the exception of the TM4-Cx45CT, all of the con-
structs were able to grow in C41(DE3) cells. When comparing
the primary sequences of the connexin isoforms, they all con-
tain rare codons (Table 2). However, TM4-Cx45CT is the only
construct that contains rare codons in tandem, which is known
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FIGURE 3 |Western blot analysis. C41(DE3)pLysS transformed with the
empty pET-14b vector (lanes 2 and 3) or theTM4-Cx45CT plasmid (lanes 5
and 6). Lane 8 contains theTM4-Cx45CT after puriﬁcation. Lane 1 contains
the Precision Plus Protein All Blue Standards molecular mass marker
(Bio-Rad) and lanes 4 and 7 are blank. Samples were collected just prior to
(lanes 2 and 5) and 4 h after IPTG induction (lanes 3 and 6). A total of
500 μL samples with an Abs600 nm at 0.5 were pelleted and resuspended
in 30 μL of 6× SDS loading buffer. Equal amounts of total protein (7 μL)
were ran on a 15% SDS-PAGE gel. (A) Coomassie Blue stained gel is
shown as a reference. Western blot analyses were performed using either
(B) anti-His6, or (C) anti-Cx45 primary antibodies. The expected molecular
mass of theTM4-Cx45CT is ∼22 kDa, which is indicated by the arrow. Of
note, in (B) lane 8, the anti-His6 primary antibody also reacted with a
∼20 Da protein. Although not present in the (A) 15% SDS-PAGE gel or
reactive with the (C) anti-Cx45 primary antibody, we speculate the doublet
is caused by proteolysis of theTM4-Cx45CT.
to inhibit protein expression (Kim and Lee, 2006). In addition,
the TM4-Cx32CT, TM4-Cx37CT, and TM4-Cx50CT constructs
were also able to grow in the C41(DE3)pLysS strain. In general,
the TM4-CxCT constructs produced more protein in LB media
FIGURE 4 | Comparison of theTM4-Cx45CT expression profile obtained
from E. coli strain C41(DE3) with the pLysS plasmid in LB and minimal
media. C41(DE3)pLysS transformed with theTM4-Cx45CT plasmid was
grown in LB medium (lanes 2 and 3), 15N-labeled M63 minimal medium
(lanes 5 and 6), and 15N-labeled M63 minimal medium supplemented with
1 g 15N-ISOGRO/L medium (lanes 8 and 9). Lane 1 contains the Precision
Plus Protein All Blue Standards molecular mass marker (Bio-Rad) and lanes
4 and 7 are blank. Samples were collected just prior to (uninduced, U) and
4 h after IPTG induction (I), as noted. A total of 500 μL samples with an
Abs600 nm at 0.5 were pelleted and resuspended in 30 μL of 6× SDS
loading buffer. Equal amounts of total protein (7 μL) were ran on a 15%
SDS-PAGE gel and stained with Coomassie Blue. TheTM4-Cx45CT has an
expected molecular mass of ∼22 kDa, indicated by the arrow.
(e.g., for CD, ITC, etc.) as compared with minimal media (i.e.,
for NMR). The only differences were the TM4-Cx43CT isoform
grew equally as well and the TM4-Cx45CT grew better in minimal
media, which is caused by the addition of 15N-ISOGRO to the
media.
CHARACTERIZATION OF THE TM4-Cx45CT SECONDARY STRUCTURE
Combining a plasmid that expresses rare tRNAs with an E. coli
strain selected to express toxic membrane proteins improved the
yield of TM4-Cx45CT to levels that are cost-effective and now fea-
sible for NMR structural studies. Using the expression protocol
developed herein, the TM4-Cx45CT was puriﬁed and reconsti-
tuted into detergent micelles (LPPG) using techniques developed
previously for the TM4-Cx43CT construct (Kellezi et al., 2008).
The purity of the TM4-Cx45CT was veriﬁed by SDS-PAGE and
Western blot analyses (Figure 3, Lane 8). Next, a 15N-HSQC
spectrum was collected to evaluate the sample properties of the
TM4-Cx45CT. The 15N-HSQC is a two-dimensional NMR exper-
iment in which each amino acid except proline gives one signal,
or chemical shift, that corresponds to the N–H amide group.
Figure 6A shows the 15N-HSQC for TM4-Cx45CT collected in
20 mM MES, 1 mM DTT, 8% LPPG, and 1 mM EDTA. Unexpect-
edly, the spectra quality is poor, and only approximately 50% of
the expected cross peaks are present. Previous studies identiﬁed
that a soluble version of the Cx45CT (K265-I396) was in a dimer
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FIGURE 5 | Growth curves of theTM4-Cx45CT. (A) Optical density of
cultures in LB media were monitored at Abs600 nm during the growth of
TM4-Cx45CT in six different E. coli strains. (B)TM4-Cx45CT grown in the
C41(DE3)pLysS stain using LB and M63 minimal media with or without
ISOGRO.The dashed line at 0 h represents the induction with IPTG.
conformation that could be disrupted by acetonitrile (Kopanic and
Sorgen, 2012). Therefore, a 15N-HSQC spectrum was collected in
the presence of 30% acetonitrile (Figure 6B), which shows the
total number (168) of expected amide cross peaks correspond-
ing to the non-proline residues of the TM4-Cx45CT. Additionally,
the number of Gly residues (12, circled and numbered) matches
the number found in the primary sequence and indicates that
the TM4-Cx45CT construct is in a single conformation. Alto-
gether, this demonstrates the feasibility of solving the monomeric
TM4-Cx45CT structure.
Circular dichroïsm was used to gain insight into the TM4-
Cx45CT secondary structure before obtaining an atomic level
structure. Intracellular acidiﬁcation is a major consequence of tis-
sue ischemia during amyocardial infarction,which leads to closure
and degradation of gap junction channels and can be a substrate
formalignant ventricular arrhythmias (Lau,2005). Therefore, data
were collected at either physiological (pH7.5) or ischemic (pH5.8)
conditions (Figure 7). The TM4-Cx45CT (without acetonitrile)
has a small increase in α-helical content under acidic conditions
FIGURE 6 | Demonstrating the feasibility of solving theTM4-Cx45CT
structure. 15N-HSQC of theTM4-Cx45CT in 20 mM MES, 1 mM DTT,
1 mM EDTA, and 8% 1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-RAC-
(1-glycerol)] detergent micelles (A) alone or (B) in the presence of 30%
deuterated acetonitrile. Highlighted are the 12 Gly residues in the
TM4-Cx45CT (dotted rectangle, numbered).
FIGURE 7 | Secondary structure of theTM4-Cx45CT. Circular dichroïsm
of theTM4-Cx45CT in 20 mM MES, 1 mM DTT, 1 mM EDTA, and 8%
1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-RAC-(1-glycerol)] detergent
micelles alone (black) or in presence of 30% acetonitrile (gray) at pH 7.5
(solid lines) and 5.8 (dashed lines).
(pH 7.5, 25%; pH 5.8, 28%). This pH-effect is similar in the pres-
ence of 30% acetonitrile with a small increase in overall α-helical
content (pH 7.5 28%; pH 5.8, 32%). The pH-induced increase
in α-helical content for the TM4-Cx45CT (3–4%) is smaller than
observed for the TM4-Cx43CT (16%; Kellezi et al., 2008; Grosely
et al., 2012).
DISCUSSION
Even though the soluble versions of connexin CT domains have
proven to be useful for describing mechanisms involved in gap
junction regulation, several results indicate that these constructs
may not be optimal. For example, the cryo-electron microscopy
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structure of the Cx43 mutant (truncated at residue T263) sug-
gested that the N-terminal region of the CT domain (S255-T263)
contains α-helical structure (Unger et al., 1999). In contrast,
the NMR data for the soluble Cx43CT (S255-I382) identiﬁed
these same residues as weak resonances, suggesting an exchange
between an unstructured and α-helical conformations (Sorgen
et al., 2004). Additionally, not all of the expected NOEs were
observed in the two dynamic α-helical regions of the soluble
CT structure. The TM4-tethered Cx43CT protein (D219-I382)
solubilized in detergent micelles offers a more native-like con-
struct for structural studies (Kellezi et al., 2008). CD and NMR
data indicated that the TM4-Cx43CT has more α-helical con-
tent than can be attributed to solely the addition of the TM4
domain to the soluble CT domain (Kellezi et al., 2008; Grosely
et al., 2012). In addition, the TM4-Cx43CT is also structurally
responsive to the changes in pH and phosphorylation, unlike the
soluble Cx43CT, indicating that this construct is a better model
for the investigation of structural-based mechanisms behind gap
junction channel regulation (Kellezi et al., 2008; Grosely et al.,
2012). Extending this study to other connexin isoforms, such as
Cx45, will allow future structural studies to characterize mech-
anisms of gap junction regulation. The motivation behind this
study is that a better understanding of the similarities and differ-
ences in structure between connexin CT domains when attached
to the TM4 can be exploited to aid in the design of chemical
modiﬁers.
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